Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics
Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics
*DJ Nestle Now Has Around 84% of Aimmune Therapeutics Shares
*DJ雀巢現在擁有AImmune治療公司約84%的股份
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:18 ET (05:18 GMT)
2020年10月13日東部時間01:18(格林尼治標準時間05:18)
*DJ Nestle's Subsidiary SPN MergerSub Offered $34.5 for Each Aimmune Therapeutics Share Not Owned by Nestle
*DJ雀巢的子公司SPN MergerSub出價34.5美元,收購每股非雀巢擁有的AImmune Treateutics股票
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:21 ET (05:21 GMT)
2020年10月13日東部時間01:21(格林尼治標準時間05:21)
*DJ Nestle: Minimum Tender Condition Has Been Satisfied
*DJ雀巢:已滿足最低投標條件
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:22 ET (05:22 GMT)
2020年10月13日東部時間01:22(格林尼治標準時間05:22)
*DJ Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics
*DJ雀巢希望將SPN MergerSub子公司與AImmune Treeutics合併
(MORE TO FOLLOW) Dow Jones Newswires
(更多後續報道)道瓊斯通訊社
October 13, 2020 01:24 ET (05:24 GMT)
2020年10月13日東部時間01:24(格林尼治標準時間05:24)
Copyright (c) 2020 Dow Jones & Company, Inc.
版權所有(C)2020道瓊斯公司。